To assess the prognostic effect of CSNK1D, we performed ROC survival rate analysis for HCC and found that CSNK1D exhibited a good prognostic evaluation effect, with AUCs of 0.742, 0.648, and 0.667 for 1 year, 3 years, and 5 years, respectively (Figure 9I). This evidence concerns the gene CSNK1D and hepatocellular carcinoma.